Norfolk, VA, April 21, 2020 — ReAlta Life Sciences, Inc., today announced that it has successfully closed an oversubscribed Series A2...
Read MoreNorfolk, VA, April 9, 2020 — ReAlta Life Sciences, Inc., a biotech company dedicated to harnessing the power of the immune...
Read MoreNorfolk, VA, March 10, 2020 — ReAlta Life Sciences, Inc., a biotechnology company dedicated to harnessing the power of the immune...
Read MoreNorfolk, VA, February 6, 2020 — ReAlta Life Sciences, Inc., today announced that U.S. Food and Drug Administration (FDA) has granted...
Read MoreTHE VIRGINIAN-PILOT | DEC 29, 2019 https://www.pilotonline.com/news/health/vp-nw-fzx19-realta-life-sciences-20191229-ufzi7vhgu5f3nppfatihjcgq3a-story.html
Read MoreNorfolk, VA, November 6, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming Complement-based Drug...
Read MoreNorfolk, VA, October 30, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming BIOEurope® 2019 – 25th...
Read MoreNorfolk, VA, September 01, 2019 — Ulrich Thienel MD, PhD, has been appointed by the ReAlta Life Sciences Board of Directors...
Read MoreNorfolk, VA, June 06, 2019 — ReAlta Life Sciences, Inc. has been awarded a $1.5 million grant by the National Institute of Allergy...
Read More